See more : Pharma Mar, S.A. (PHMMF) Income Statement Analysis – Financial Results
Complete financial analysis of Artrya Limited (AYA.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Artrya Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Nippon Rietec Co.,Ltd. (1938.T) Income Statement Analysis – Financial Results
- Airlux Electrical Co., Ltd. (4609.TWO) Income Statement Analysis – Financial Results
- DCP Midstream, LP (DCP-PC) Income Statement Analysis – Financial Results
- HG Semiconductor Limited (6908.HK) Income Statement Analysis – Financial Results
- Shree Renuka Sugars Limited (RENUKA.BO) Income Statement Analysis – Financial Results
Artrya Limited (AYA.AX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.artrya.com
About Artrya Limited
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 13.25M | 552.00K | 202.00K | 38.51K | 11.54K | 90.00 |
| Gross Profit | -13.25M | -552.00K | -202.00K | -38.51K | -11.54K | -90.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 470.00K | 6.70M | 8.99M | 239.00K | 117.78K | 0.00 |
| Selling & Marketing | 90.00K | 212.00K | 1.70M | 265.00K | 55.00 | 0.00 |
| SG&A | 972.00K | 11.89M | 10.68M | 4.20M | 1.74M | 145.57K |
| Other Expenses | 0.00 | 19.00K | 113.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.15M | 11.87M | 16.79M | 4.20M | 1.74M | 145.57K |
| Cost & Expenses | 14.40M | 12.42M | 16.79M | 4.24M | 1.76M | 145.66K |
| Interest Income | 458.00K | 404.00K | 73.00K | 2.00 | 4.00 | 0.00 |
| Interest Expense | 31.00K | 58.00K | 7.00K | 26.75K | 6.60K | 10.00 |
| Depreciation & Amortization | 403.00K | 552.00K | 202.00K | 38.51K | 11.54K | 90.00 |
| EBITDA | -13.96M | -10.51M | -16.40M | -4.01M | -1.34M | -145.57K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.40M | -12.42M | -16.61M | -4.24M | -1.76M | -145.66K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 427.00K | 346.00K | 165.00K | 159.93K | -6.60K | -14.00 |
| Income Before Tax | -13.97M | -11.12M | -16.62M | -4.08M | -1.35M | -145.67K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 27.00K | 18.00K | 535.00K | -5.00 | -4.00 | -171.77K |
| Net Income | -14.00M | -11.14M | -17.16M | -4.08M | -1.35M | -145.67K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.18 | -0.14 | -0.26 | -0.12 | -0.06 | 0.00 |
| EPS Diluted | -0.18 | -0.14 | -0.26 | -0.12 | -0.06 | 0.00 |
| Weighted Avg Shares Out | 78.64M | 78.37M | 66.18M | 34.43M | 22.34M | 78.11M |
| Weighted Avg Shares Out (Dil) | 78.64M | 78.38M | 66.18M | 34.43M | 22.34M | 78.11M |
Source: https://incomestatements.info
Category: Stock Reports